FDG-PET and MRI-features of the Fabry patients.
收藏NIAID Data Ecosystem2026-03-09 收录
数据链接:
官方服务:
资源简介:
n.a.not applicable -WML grade 0 or pathology not present - / -no changes in neither PET nor MRI a Patient no. 5: symmetrical mildly reduced activity parietotemporally bilaterally b Patient no. 22: symmetrical mildly reduced activity in both thalami Cont. c Progression of pathology on either PET or MRI was detected in the following patients: Patient no. 3: PET-study period: seven years Patient no. 4: PET-study period: six years. Patient no. 8: MRI study period: three years Patient no. 9: PET-study period: five years. MRI study period: seven years. Patient no. 19: MRI study period: five years Patient no. 25: PET/MRI study period: two years. FDG-PET and MRI-features of the Fabry patients.
创建时间:
2015-12-08



